Cargando…
The Interaction of Selenium with Chemotherapy and Radiation on Normal and Malignant Human Mononuclear Blood Cells
Selenium, a trace element with anticancer properties, can reduce harmful toxicities of chemotherapy and radiotherapy without compromising efficacy. However, the dose-response relationship in normal versus malignant human cells is unclear. We evaluated how methylseleninic acid (MSA) modulates the tox...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214079/ https://www.ncbi.nlm.nih.gov/pubmed/30326581 http://dx.doi.org/10.3390/ijms19103167 |
_version_ | 1783367919501049856 |
---|---|
author | Lobb, Richard J. Jacobson, Gregory M. Cursons, Ray T. Jameson, Michael B. |
author_facet | Lobb, Richard J. Jacobson, Gregory M. Cursons, Ray T. Jameson, Michael B. |
author_sort | Lobb, Richard J. |
collection | PubMed |
description | Selenium, a trace element with anticancer properties, can reduce harmful toxicities of chemotherapy and radiotherapy without compromising efficacy. However, the dose-response relationship in normal versus malignant human cells is unclear. We evaluated how methylseleninic acid (MSA) modulates the toxicity and efficacy of chemotherapy and radiation on malignant and non-malignant human mononuclear blood cells in vitro. We specifically investigated its effects on endoplasmic reticulum stress induction, intracellular glutathione concentration, DNA damage and viability of peripheral blood mononuclear cells and THP1 monocytic leukaemia cells in response to radiation, cytosine arabinoside or doxorubicin chemotherapy. MSA, at lower concentrations, induced protective responses in normal cells but cytotoxic effects in malignant cells, alone and in conjunction with chemotherapy or radiation. However, in normal cells higher concentrations of MSA were directly toxic and increased the cytotoxicity of radiation but not chemotherapy. In malignant cells higher MSA concentrations were generally more effective in combination with cancer treatments. Thus, optimal MSA concentrations differed between normal and malignant cells and treatments. This work supports clinical reports that selenium can significantly reduce dose-limiting toxicities of anticancer therapies and potentially improve efficacy of anticancer treatments. The optimal selenium compound and dose is not yet determined. |
format | Online Article Text |
id | pubmed-6214079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62140792018-11-14 The Interaction of Selenium with Chemotherapy and Radiation on Normal and Malignant Human Mononuclear Blood Cells Lobb, Richard J. Jacobson, Gregory M. Cursons, Ray T. Jameson, Michael B. Int J Mol Sci Article Selenium, a trace element with anticancer properties, can reduce harmful toxicities of chemotherapy and radiotherapy without compromising efficacy. However, the dose-response relationship in normal versus malignant human cells is unclear. We evaluated how methylseleninic acid (MSA) modulates the toxicity and efficacy of chemotherapy and radiation on malignant and non-malignant human mononuclear blood cells in vitro. We specifically investigated its effects on endoplasmic reticulum stress induction, intracellular glutathione concentration, DNA damage and viability of peripheral blood mononuclear cells and THP1 monocytic leukaemia cells in response to radiation, cytosine arabinoside or doxorubicin chemotherapy. MSA, at lower concentrations, induced protective responses in normal cells but cytotoxic effects in malignant cells, alone and in conjunction with chemotherapy or radiation. However, in normal cells higher concentrations of MSA were directly toxic and increased the cytotoxicity of radiation but not chemotherapy. In malignant cells higher MSA concentrations were generally more effective in combination with cancer treatments. Thus, optimal MSA concentrations differed between normal and malignant cells and treatments. This work supports clinical reports that selenium can significantly reduce dose-limiting toxicities of anticancer therapies and potentially improve efficacy of anticancer treatments. The optimal selenium compound and dose is not yet determined. MDPI 2018-10-15 /pmc/articles/PMC6214079/ /pubmed/30326581 http://dx.doi.org/10.3390/ijms19103167 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lobb, Richard J. Jacobson, Gregory M. Cursons, Ray T. Jameson, Michael B. The Interaction of Selenium with Chemotherapy and Radiation on Normal and Malignant Human Mononuclear Blood Cells |
title | The Interaction of Selenium with Chemotherapy and Radiation on Normal and Malignant Human Mononuclear Blood Cells |
title_full | The Interaction of Selenium with Chemotherapy and Radiation on Normal and Malignant Human Mononuclear Blood Cells |
title_fullStr | The Interaction of Selenium with Chemotherapy and Radiation on Normal and Malignant Human Mononuclear Blood Cells |
title_full_unstemmed | The Interaction of Selenium with Chemotherapy and Radiation on Normal and Malignant Human Mononuclear Blood Cells |
title_short | The Interaction of Selenium with Chemotherapy and Radiation on Normal and Malignant Human Mononuclear Blood Cells |
title_sort | interaction of selenium with chemotherapy and radiation on normal and malignant human mononuclear blood cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214079/ https://www.ncbi.nlm.nih.gov/pubmed/30326581 http://dx.doi.org/10.3390/ijms19103167 |
work_keys_str_mv | AT lobbrichardj theinteractionofseleniumwithchemotherapyandradiationonnormalandmalignanthumanmononuclearbloodcells AT jacobsongregorym theinteractionofseleniumwithchemotherapyandradiationonnormalandmalignanthumanmononuclearbloodcells AT cursonsrayt theinteractionofseleniumwithchemotherapyandradiationonnormalandmalignanthumanmononuclearbloodcells AT jamesonmichaelb theinteractionofseleniumwithchemotherapyandradiationonnormalandmalignanthumanmononuclearbloodcells AT lobbrichardj interactionofseleniumwithchemotherapyandradiationonnormalandmalignanthumanmononuclearbloodcells AT jacobsongregorym interactionofseleniumwithchemotherapyandradiationonnormalandmalignanthumanmononuclearbloodcells AT cursonsrayt interactionofseleniumwithchemotherapyandradiationonnormalandmalignanthumanmononuclearbloodcells AT jamesonmichaelb interactionofseleniumwithchemotherapyandradiationonnormalandmalignanthumanmononuclearbloodcells |